The global life sciences (LS) industry is undergoing structural change, with the focus shifting from healthcare providers and drug manufacturing to being patient-centered and improving quality of care. In the context of increasingly stringent regulatory review, patent cliffs, and an
increase in generic drugs, the industry faces multiple challenges and cost pressures. Pharmaceutical companies are increasingly using the power of next-generation technologies to optimize their business processes, improve the efficiency of clinical trials, and optimize drug manufacturing and distribution. They are also turning to digital to better meet emerging patient expectations and strengthen efforts around patient education and segmentation, experience management, and drug delivery. Also very concerned about compliance and cost reduction.